M1 AND/OR M3 RECEPTOR ANTAGONISTS IN COMBINATION WITH OTHER ACTIVES FOR TREATING RESPIRATORY DISORDERS
摘要
<p>The present invention relates to formulations useful for treating respiratory disorders associated with the production of mucus glycoprotein, skin disorders, and allergic conjunctivitis while substantially reducing adverse effects associated with the administration of non-selective anti-cholinergic agents and methods of use thereof. In particular, the formulations include a selective muscarinic acetylcholdine receptor subtype M1 and/or M3 antagonist such as oxybutynin in combination with one or more pharmaceutically active agents, such as desloratidine.</p>
申请公布号
WO2006047427(A1)
申请公布日期
2006.05.04
申请号
WO2005US38208
申请日期
2005.10.24
申请人
SCHERING CORPORATION;LORBER, RICHARD, R.;STAUDINGER, HERIBERT;WARD, ROBERT, E.
发明人
LORBER, RICHARD, R.;STAUDINGER, HERIBERT;WARD, ROBERT, E.